All filters
Abstracts
Maintaining epidemic control in Namibia: designing the optimal package - Lessons from ACS support to the Namibian Government
E. Owino
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Policy adoption of WHO’s HIV retesting policy for HIV-negative women during the breastfeeding period: An analysis of 10 high HIV-burden African Countries
B. Burmen
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Contribution of assisted partner notification to identification of undiagnosed HIV infection among sexual partners of HIV positive index clients in mid-western Uganda: a retrospective review of program data.
E. Mugisa
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Performance-based Incentives – a means to sustainably optimise healthcare worker performance to achieve 90-90-90 targets in South Africa
J. Miot
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Fostering Key populations inclusion through a regional approach: The Southern African Development Community (SADC) case
L. Kumboneki
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Measuring Nigeria’s progress in attaining the Global HIV Prevention Coalition targets of ending AIDS by 2030 -– a review of the national scorecard and HIV prevention 2020 road map
K. Essomeonu
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
HIV rapid testing trends among clients aged 50 years and above in Uganda: A need for targeted prevention services for the elderly.
M. Johnbosco
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Knowledge, Attitude and Perception of Pharmacy and Medical Students in Nigeria towards HIV Pre-Exposure Prophylaxis (PrEP).
M. Okereke
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Towards 90-90-90 target: Examining the Knowledge and Perception of MSM in Nigeria towards HIV/AIDS.
M. Okereke
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Botswana’s Provision of Free HIV Treatment for Noncitizens Brings Them Out to Test
W. Dikobe
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Females Who Inject Drugs in Nigeria - Lessons from Key Population Size Estimation Study of 10 States
A. Adesina
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
The Contribution of HIV Viral Load in Improving the Accuracy of Recent Infection Testing in Rwanda
V. Mbonitegeka
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Point of Care SAMBA-II vs Central Laboratory monitoring of HIV-1 Infected Children, Adolescents and Young Adults in Rural Zimbabwe.
V. Kouamou
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Evaluation of Viral Load Coverage and Suppression Rates in the GlobalFund Impact HIV Project in Nigeria; June 2017 – November 2019
H. Adiamoh
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Operational cost per test of cryptococcal antigen (CrAg) reflexed testing in South Africa in the light of proposed inclusion of samples with a CD4 count between 100-200cells/µl
L. Coetzee
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Post-market assessment of two rapid diagnostic test kits used in the diagnosis of HIV in the Wa Municipality, Ghana
D. Amoatika
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Assessing the operational impact of guideline changes to Cryptococcal antigen (CrAg) testing to include samples with a CD4 count of 100-200 cells/µl on a national reflex testing program in South Africa (SA): a desktop exercise using laboratory data
L. Coetzee
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Best practices for statistical method comparison to evaluate new plasma separation devices as alternatives to plasma-based HIV viral load monitoring
T. Mampa
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Pregnant women at higher risk of hepatotoxicity when initiating TDF/3TC/EFV in Malawi
E. Singogo
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Viral load access for key population implemented at community-based clinic in Mali
J. Bashi Bagendabanga
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
The Abbott Alinity m HIV-1 viral assay verified for testing PPT specimens in a centralised laboratory setting in South Africa
L. Hans
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Accessibility of Point-of-Care Diagnostics in Rural and Remote Primary Health Care Facilities in Zambia: A Cross-Sectional Survey
J. Katoba
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
The performance of the cobas® plasma separation card for HIV viral load testing using the Abbott m2000 platform
L. Noble
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Performance Characteristics of a Modified HIV-1 Drug Resistance Genotyping Method for use in Resource Limited Settings
E. Magomere
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020